These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19819970)

  • 1. Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
    Gayen JR; Gu Y; O'Connor DT; Mahata SK
    Endocrinology; 2009 Nov; 150(11):5027-35. PubMed ID: 19819970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment.
    Dev NB; Gayen JR; O'Connor DT; Mahata SK
    Endocrinology; 2010 Jun; 151(6):2760-8. PubMed ID: 20410203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene.
    Gayen JR; Zhang K; RamachandraRao SP; Mahata M; Chen Y; Kim HS; Naviaux RK; Sharma K; Mahata SK; O'Connor DT
    Circ Cardiovasc Genet; 2010 Oct; 3(5):414-25. PubMed ID: 20729505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortin 2 lowers blood pressure and reduces plasma catecholamine levels in mice with hyperadrenergic activity.
    Gu Y; Zhang K; Biswas N; Friese RS; Lin DH; Mahata SK; Hoshijima M; O'Connor DT; Peterson KL; Brar BK
    Endocrinology; 2010 Oct; 151(10):4820-9. PubMed ID: 20668031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses.
    Vaingankar SM; Li Y; Biswas N; Gayen J; Choksi S; Rao F; Ziegler MG; Mahata SK; O'Connor DT
    J Hypertens; 2010 Apr; 28(4):817-25. PubMed ID: 20139771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac electrical activity in a genomically "humanized" chromogranin a monogenic mouse model with hyperadrenergic hypertension.
    Dev NB; Mir SA; Gayen JR; Siddiqui JA; Mustapic M; Vaingankar SM
    J Cardiovasc Transl Res; 2014 Jul; 7(5):483-493. PubMed ID: 24821335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catestatin: A Master Regulator of Cardiovascular Functions.
    Mahata SK; Kiranmayi M; Mahapatra NR
    Curr Med Chem; 2018; 25(11):1352-1374. PubMed ID: 28443506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long human CHGA flanking chromosome 14 sequence required for optimal BAC transgenic "rescue" of disease phenotypes in the mouse Chga knockout.
    Vaingankar SM; Li Y; Corti A; Biswas N; Gayen J; O'Connor DT; Mahata SK
    Physiol Genomics; 2010 Mar; 41(1):91-101. PubMed ID: 20009010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catestatin: a multifunctional peptide from chromogranin A.
    Mahata SK; Mahata M; Fung MM; O'Connor DT
    Regul Pept; 2010 Jun; 162(1-3):33-43. PubMed ID: 20116404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling.
    Bandyopadhyay GK; Vu CU; Gentile S; Lee H; Biswas N; Chi NW; O'Connor DT; Mahata SK
    J Biol Chem; 2012 Jun; 287(27):23141-51. PubMed ID: 22535963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprint of: Catestatin: a multifunctional peptide from chromogranin A.
    Mahata SK; Mahata M; Fung MM; O'Connor DT
    Regul Pept; 2010 Nov; 165(1):52-62. PubMed ID: 20965217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis and validation of traits associated with a single nucleotide polymorphism Gly364Ser in catestatin using humanized chromogranin A mouse models.
    Mir SA; Zhang K; Milic M; Gu Y; Rieg T; Ziegler M; Vaingankar SM
    J Hypertens; 2016 Jan; 34(1):68-78. PubMed ID: 26556564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion.
    Chen Y; Rao F; Rodriguez-Flores JL; Mahata M; Fung MM; Stridsberg M; Vaingankar SM; Wen G; Salem RM; Das M; Cockburn MG; Schork NJ; Ziegler MG; Hamilton BA; Mahata SK; Taupenot L; O'Connor DT
    J Am Coll Cardiol; 2008 Oct; 52(18):1468-81. PubMed ID: 19017515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway.
    Kiranmayi M; Chirasani VR; Allu PK; Subramanian L; Martelli EE; Sahu BS; Vishnuprabu D; Kumaragurubaran R; Sharma S; Bodhini D; Dixit M; Munirajan AK; Khullar M; Radha V; Mohan V; Mullasari AS; Naga Prasad SV; Senapati S; Mahapatra NR
    Hypertension; 2016 Aug; 68(2):334-47. PubMed ID: 27324226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranin A: a surprising link between granule biogenesis and hypertension.
    Kim T; Loh YP
    J Clin Invest; 2005 Jul; 115(7):1711-3. PubMed ID: 16007250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.
    Mahapatra NR; O'Connor DT; Vaingankar SM; Hikim AP; Mahata M; Ray S; Staite E; Wu H; Gu Y; Dalton N; Kennedy BP; Ziegler MG; Ross J; Mahata SK
    J Clin Invest; 2005 Jul; 115(7):1942-52. PubMed ID: 16007257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification.
    Friese RS; Gayen JR; Mahapatra NR; Schmid-Schönbein GW; O'Connor DT; Mahata SK
    Physiol Genomics; 2010 Feb; 40(3):195-207. PubMed ID: 19952279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice overexpressing chromogranin A display hypergranulogenic adrenal glands with attenuated ATP levels contributing to the hypertensive phenotype.
    Mir SA; Li Y; Story JD; Bal S; Awdishu L; Street AA; Mehta RL; Singh P; Vaingankar SM
    J Hypertens; 2018 May; 36(5):1115-1128. PubMed ID: 29389743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
    Rao F; Wen G; Gayen JR; Das M; Vaingankar SM; Rana BK; Mahata M; Kennedy BP; Salem RM; Stridsberg M; Abel K; Smith DW; Eskin E; Schork NJ; Hamilton BA; Ziegler MG; Mahata SK; O'Connor DT
    Circulation; 2007 May; 115(17):2271-81. PubMed ID: 17438154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 9 plays a key role in the autonomic cardiac and baroreflex control of arterial pressure.
    Rodrigues FL; Silva LE; Hott SC; Bomfim GF; da Silva CA; Fazan R; Resstel LB; Tostes RC; Carneiro FS
    Am J Physiol Regul Integr Comp Physiol; 2015 Apr; 308(8):R714-23. PubMed ID: 25673780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.